Cencora — Fiscal 2026 Fourth Quarter Earnings Summary

Cencora reported fiscal 2026 fourth-quarter revenue of $88.4 billion, representing a 5.5 percent increase year-over-year, while full-year revenue reached $337.4 billion, up 5.0 percent. The company recorded GAAP diluted earnings per share of $2.71 for the quarter and $17.95 for the fiscal year, with adjusted diluted EPS reaching $4.66 and $17.97 respectively. Cencora announced a new organizational structure effective in fiscal 2027, introducing segments for Pharmaceutical Distribution and Services and Specialty Pharmaceutical and Provider Services. Looking ahead, the company expects fiscal 2027 adjusted diluted EPS to range between $19.40 and $19.75, reflecting 8 to 10 percent growth, and declared a 10 percent increase in its quarterly dividend to $0.66 per share.